List of Qbrelis drug patents

Qbrelis is owned by Azurity.

Qbrelis contains Lisinopril.

Qbrelis has a total of 8 drug patents out of which 0 drug patents have expired.

Qbrelis was authorised for market use on 29 July, 2016.

Qbrelis is available in solution;oral dosage forms.

Qbrelis can be used as acute myocardial infarction; treatment of myocardial infarction; reduction of mortality in acute myocardial infarction; method of treatment of heart failure; treatment of heart failure; treatment of hypertension; method of treating hypertension, treatment of myocardial infarction; method of treating hypertension; treatment of heart failure; method of treatment of heart failure; reduction of mortality in acute myocardial infarction; treatment of hypertension; acute myocardial infarction, treatment of hypertension; method of treating hypertension; treatment of heart failure; treatment of myocardial infarction; reduction of mortality in acute myocardial infarction; acute myocardial infarction; method of treatment of heart failure.

The generics of Qbrelis are possible to be released after 06 November, 2035.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9616096 AZURITY Lisinopril formulations
Nov, 2035

(12 years from now)

US10039800 AZURITY Lisinopril formulations
Nov, 2035

(12 years from now)

US10406199 AZURITY Lisinopril formulations
Nov, 2035

(12 years from now)

US10265370 AZURITY Lisinopril formulations
Nov, 2035

(12 years from now)

US9463183 AZURITY Lisinopril formulations
Nov, 2035

(12 years from now)

US11179434 AZURITY Lisinopril formulations
Nov, 2035

(12 years from now)

US10940177 AZURITY Lisinopril formulations
Nov, 2035

(12 years from now)

US9814751 AZURITY Lisinopril formulations
Nov, 2035

(12 years from now)

Drugs and Companies using LISINOPRIL ingredient

Market Authorisation Date: 29 July, 2016

Treatment: Treatment of hypertension; Method of treating hypertension; Treatment of heart failure; Treatment of myocardial infarction; Reduction of mortality in acute myocardial infarction; Acute myocardial infarction; Method of treatment of heart failure

Dosage: SOLUTION;ORAL

How can I launch a generic of QBRELIS before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in